4.4 Article

Differential cytokine responses from primary human Kupffer cells following infection with wild-type or vaccine strain yellow fever virus

期刊

VIROLOGY
卷 412, 期 1, 页码 188-195

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2011.01.012

关键词

Kupffer cell; Yellow fever virus; IL-8; IL-10; RANTES/CCL5; TNF-alpha

类别

向作者/读者索取更多资源

Wild-type yellow fever virus (YFV) infections result in a hepatotropic disease which is often fatal, while vaccination with the live-attenuated 17-D strain results in productive infection yet is well-tolerated with few adverse events. Kupffer cells (KCs) are resident liver macrophages that have a significant role in pathogen detection, clearance and immune signaling. Although KCs appear to be an important component of YF disease, their role has been under-studied. This study examined cytokine responses in KCs following infection with either wild-type or vaccine strains of YFV. Results indicate that KCs support replication of wild-type and vaccine strains, yet wild-type YFV induced a prominent and prolonged pro-inflammatory cytokine response (IL-8, TNF-alpha and RANTES/CCL5) with little control by a major anti-inflammatory cytokine (IL-10). This response was significantly reduced in vaccine strain infections. These data suggest that a differentially regulated infection in KCs may play a critical role in development of disease. (c) 2011 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pathology

Expanded Histopathology and Tropism of Ebola Virus in the Rhesus Macaque Model Potential for Sexual Transmission, Altered Adrenomedullary Hormone Production, and Early Viral Replication in Liver

David X. Liu, Timothy K. Cooper, Donna L. Perry, Louis M. Huzella, Amanda M. W. Hischak, Randy J. Hart, Nejra Isic, Russell Byrum, Danny Ragland, Marisa St Claire, Kurt Cooper, Rebecca Reeder, James Logue, Peter B. Jahrling, Michael R. Holbrook, Richard S. Bennett, Lisa E. Hensley

Summary: The study found that Ebola virus can cause various reproductive organ diseases and replicates in other organs as well, providing new perspectives on sexual transmission, disruption of hormone production, and early virus replication in human EVD patients.

AMERICAN JOURNAL OF PATHOLOGY (2022)

Article Medicine, General & Internal

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

Mark N. Polizzotto, Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu, Vivian Kwaghe, Roger Paredes, Lourdes Mateu, Srikanth Ramachandruni, Rajeev Narang, Manua K. Jain, Susana M. Lazarte, Jason Baker, Anne E. P. Frosch, Garyfallia Poulakou, Konstantinos N. Syrigos, Gretchen S. Amoczy, Natalie A. McBride, Philip A. Robinson, Farjad Sarafian, Sanjay Bhagani, I. Lassan S. Taha, Thomas Benfield, Sean T. H. Liu, Anastasia Antoniadou, Jens Ulrik Staehr Jensen, Ioannis Kalomenidis, Adityo Susilo, Prasetyo Hariadi, Tomas O. Jensen, Jose Luis Morales-Rull, Marie Helleberg, Sreenath Meegada, Isik S. Johansen, Daniel Canario, Eduardo Fernandez-Cruz, Simeon Metallidis, Amish Shah, Aki Sakurai, Nikolaus G. Koulouris, Robin Trounan, Amy C. Weintrob, Dania Podlekareva, Usman Hadi, Kathryn M. Lloyd, Birgit Thorup Roge, Sho Saito, Kelly Sweenis, Jakob J. Malin, Christoph Luebbert, Jose Munoz, Matthew J. Cummings, Marcelo H. Losso, Dan Turner, Kathryn Shaw-Saliba, Robin Dewar, Helene Highbarger, Pertine Lallemand, Tauseef Rehman, Norman Gerry, Dona Arlinda, Christina C. Chang, Birgit Grund, Michael R. Holbrook, Horace P. Holley, Fleur Hudson, Laura A. McNay, Daniel D. Murray, Sarah L. Pett, Megan Shaughnessy, Mary C. Smolslcis, Giota Touloumi, Mary F. Wright, Mittie K. Doyle, Sharon Popik, Christine Hall, Roshan Ramanathan, Huyen Cao, Elsa Mondou, Todd Willis, Joseph Thakuria, Leman Yel, Elizabeth Liggs, Virginia L. Kan, Jens D. Lundgren, James D. Neaton, H. Clifford Lane

Summary: Passive immunotherapy using hyperimmune intravenous immunoglobulin (hIVIG) derived from recovered donors is a potential therapy for COVID-19. However, this international randomized controlled trial found that hIVIG did not demonstrate efficacy among hospitalized COVID-19 patients when administered with standard care including remdesivir.

LANCET (2022)

Article Microbiology

Tilorone-Dihydrochloride Protects against Rift Valley Fever Virus Infection and Disease in the Mouse Model

Kendra N. Johnson, Birte Kalveram, Jennifer K. Smith, Lihong Zhang, Terry Juelich, Colm Atkins, Tetsuro Ikegami, Alexander N. Freiberg

Summary: The antiviral drug Tilorone has been found to effectively inhibit Rift Valley fever virus (RVFV) infection in vitro and in vivo, suggesting its potential use as a therapeutic option for treating RVFV infection.

MICROORGANISMS (2022)

Article Biochemistry & Molecular Biology

Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses

Jacob C. Milligan, Carl W. Davis, Xiaoying Yu, Philipp A. Ilinykh, Kai Huang, Peter J. Halfmann, Robert W. Cross, Viktoriya Borisevich, Krystle N. Agans, Joan B. Geisbert, Chakravarthy Chennareddy, Arthur J. Goff, Ashley E. Piper, Sean Hui, Kelly C. L. Shaffer, Tierra Buck, Megan L. Heinrich, Luis M. Branco, Ian Crozier, Michael R. Holbrook, Jens H. Kuhn, Yoshihiro Kawaoka, Pamela J. Glass, Alexander Bukreyev, Thomas W. Geisbert, Gabriella Worwa, Rafi Ahmed, Erica Ollmann Saphire

Summary: Researchers have discovered two antibodies that can neutralize and protect against Ebola virus and Sudan virus, providing potential clinical value in treating Ebola virus infections. These antibodies were found to recognize specific regions on the viral surface, offering a new approach for developing treatments against ebolaviruses.
Article Multidisciplinary Sciences

Defining the risk of SARS-CoV-2 variants on immune protection

Marciela M. DeGrace, Elodie Ghedin, Matthew B. Frieman, Florian Krammer, Alba Grifoni, Arghavan Alisoltani, Galit Alter, Rama R. Amara, Ralph S. Baric, Dan H. Barouch, Jesse D. Bloom, Louis-Marie Bloyet, Gaston Bonenfant, Adrianus C. M. Boon, Eli A. Boritz, Debbie L. Bratt, Traci L. Bricker, Liliana Brown, William J. Buchser, Juan Manuel Carreno, Liel Cohen-Lavi, Tamarand L. Darling, Meredith E. Davis-Gardner, Bethany L. Dearlove, Han Di, Meike Dittmann, Nicole A. Doria-Rose, Daniel C. Douek, Christian Drosten, Venkata-Viswanadh Edara, Ali Ellebedy, Thomas P. Fabrizio, Guido Ferrari, Will M. Fischer, William C. Florence, Ron A. M. Fouchier, John Franks, Adolfo Garcia-Sastre, Adam Godzik, Ana Silvia Gonzalez-Reiche, Aubree Gordon, Bart L. Haagmans, Peter J. Halfmann, David D. Ho, Michael R. Holbrook, Yaoxing Huang, Sarah L. James, Lukasz Jaroszewski, Trushar Jeevan, Robert M. Johnson, Terry C. Jones, Astha Joshi, Yoshihiro Kawaoka, Lisa Kercher, Marion P. G. Koopmans, Bette Korber, Eilay Koren, Richard A. Koup, Eric B. LeGresley, Jacob E. Lemieux, Mariel J. Liebeskind, Zhuoming Liu, Brandi Livingston, James P. Logue, Yang Luo, Adrian B. McDermott, Margaret J. McElrath, Victoria A. Meliopoulos, Vineet D. Menachery, David C. Montefiori, Barbara Muehlemann, Vincent J. Munster, Jenny E. Munt, Manoj S. Nair, Antonia Netzl, Anna M. Niewiadomska, Sijy O'Dell, Andrew Pekosz, Stanley Perlman, Marjorie C. Pontelli, Barry Rockx, Morgane Rolland, Paul W. Rothlauf, Sinai Sacharen, Richard H. Scheuermann, Stephen D. Schmidt, Michael Schotsaert, Stacey Schultz-Cherry, Robert A. Seder, Mayya Sedova, Alessandro Sette, Reed S. Shabman, Xiaoying Shen, Pei-Yong Shi, Maulik Shukla, Viviana Simon, Spencer Stumpf, Nancy J. Sullivan, Larissa B. Thackray, James Theiler, Paul G. Thomas, Sanja Trifkovic, Sina Tureli, Samuel A. Turner, Maria A. Vakaki, Harm van Bakel, Laura A. VanBlargan, Leah R. Vincent, Zachary S. Wallace, Li Wang, Maple Wang, Pengfei Wang, Wei Wang, Scott C. Weaver, Richard J. Webby, Carol D. Weiss, David E. Wentworth, Stuart M. Weston, Sean P. J. Whelan, Bradley M. Whitener, Samuel H. Wilks, Xuping Xie, Baoling Ying, Hyejin Yoon, Bin Zhou, Tomer Hertz, Derek J. Smith, Michael S. Diamond, Diane J. Post, Mehul S. Suthar

Summary: The SAVE program is a real-time risk assessment initiative established by the National Institute of Allergy and Infectious Diseases to address the public health threat posed by the emergence of SARS-CoV-2 variants. Its goal is to evaluate the potential impact of these variants on transmission, virulence, and immunity induced through infection or vaccination.

NATURE (2022)

Article Cell Biology

The RNA helicase DHX16 recognizes specific viral RNA to trigger RIG-I-dependent innate antiviral immunity

Adam Hage, Preeti Bharaj, Sarah van Tol, Maria Giraldo, Maria Gonzalez-Orozco, Karl M. Valerdi, Abbey N. Warren, Leopoldo Aguilera-Aguirre, Xuping Xie, Steven G. Widen, Hong M. Moulton, Benhur Lee, Jeffrey R. Johnson, Nevan J. Krogan, Adolfo Garcia-Sastre, Pei-Yong Shi, Alexander N. Freiberg, Ricardo Rajsbaum

Summary: This study identifies the RNA helicase DHX16 as a pattern recognition receptor (PRR) that partners with RIG-I for optimal activation of antiviral immunity requiring unanchored polyubiquitin (poly-Ub).

CELL REPORTS (2022)

Article Medicine, Research & Experimental

T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity

Rebecca Elyanow, Thomas M. Snyder, Sudeb C. Dalai, Rachel M. Gittelman, Jim Boonyaratanakornkit, Anna Wald, Stacy Selke, Mark H. Wener, Chihiro Morishima, Alexander L. Greninger, Michael Gale, Tien-Ying Hsiang, Lichen Jing, Michael R. Holbrook, Ian M. Kaplan, H. Jabran Zahid, Damon H. May, Jonathan M. Carlson, Lance Baldo, Thomas Manley, Harlan S. Robins, David M. Koelle

Summary: This study suggests that measuring T cell responses can provide reliable assessment of past SARS-CoV-2 infection and protective immunity. T cell responses showed significant correlations with neutralizing antibody titers and disease severity indicators. T cell testing demonstrated high sensitivity even after 6 months of infection, outperforming serology tests in identifying prior infection, especially in individuals with milder disease.

JCI INSIGHT (2022)

Article Multidisciplinary Sciences

Broadly neutralizing antibodies target the coronavirus fusion peptide

Cherrelle Dacon, Courtney Tucker, Linghang Peng, Chang-Chun D. Lee, Ting-Hui Lin, Meng Yuan, Yu Cong, Lingshu Wang, Lauren Purser, Jazmean K. Williams, Chul-Woo Pyo, Ivan Kosik, Zhe Hu, Ming Zhao, Divya Mohan, Andrew J. R. Cooper, Mary Peterson, Jeff Skinner, Saurabh Dixit, Erin Kollins, Louis Huzella, Donna Perry, Russell Byrum, Sanae Lembirik, David Drawbaugh, Brett Eaton, Yi Zhang, Eun Sung Yang, Man Chen, Kwanyee Leung, Rona S. Weinberg, Amarendra Pegu, Daniel E. Geraghty, Edgar Davidson, Iyadh Douagi, Susan Moir, Jonathan W. Yewdell, Connie Schmaljohn, Peter D. Crompton, Michael R. Holbrook, David Nemazee, John R. Mascola, Ian A. Wilson, Joshua Tan

Summary: This study identified six monoclonal antibodies that bind to spike proteins from all seven human-infecting coronaviruses. Two of these antibodies, COV44-62 and COV44-79, showed broad neutralizing activity against alpha- and betacoronaviruses, including the Omicron subvariants of SARS-CoV-2. The fusion peptide region in the spike protein was found to be a potential candidate epitope for next-generation coronavirus vaccine development.

SCIENCE (2022)

Article Immunology

Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment

Brian P. Epling, Joseph M. Rocco, Kristin L. Boswell, Elizabeth Laidlaw, Frances Galindo, Anela Kellogg, Sanchita Das, Allison Roder, Elodie Ghedin, Allie Kreitman, Robin L. Dewar, Sophie E. M. Kelly, Heather Kalish, Tauseef Rehman, Jeroen Highbarger, Adam Rupert, Gregory Kocher, Michael R. Holbrook, Andrea Lisco, Maura Manion, Richard A. Koup, Irini Sereti

Summary: Treatment with Nirmatrelvir/ritonavir does not hinder immune responses to SARS-CoV-2. Clinical rebound is associated with the development of a robust antibody and T-cell immune response, indicating a low risk of disease progression. The presence of infectious virus supports the need for isolation and assessment of longer treatment courses.

CLINICAL INFECTIOUS DISEASES (2023)

Article Cell Biology

Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants

Zhaochun Chen, Peng Zhang, Yumiko Matsuoka, Yaroslav Tsybovsky, Kamille West, Celia Santos, Lisa F. Boyd, Hanh Nguyen, Anna Pomerenke, Tyler Stephens, Adam S. Olia, Baoshan Zhang, Valeria De Giorgi, Michael R. Holbrook, Robin Gross, Elena Postnikova, Nicole L. Garza, Reed F. Johnson, David H. Margulies, Peter D. Kwong, Harvey J. Alter, Ursula J. Buchholz, Paolo Lusso, Patrizia Farci

Summary: This study reports the generation and characterization of two potent human monoclonal antibodies against the SARS-CoV-2 spike protein. The antibodies show broad and potent neutralizing activity against the major SARS-CoV-2 variants of concern and demonstrate in vivo protective and therapeutic efficacy in a hamster model.

CELL REPORTS (2022)

Article Microbiology

Powassan Virus Induces Structural Changes in Human Neuronal Cells In Vitro and Murine Neurons In Vivo

Jacob Nelson, Lorenzo Ochoa, Paula Villareal, Tiffany Dunn, Ping Wu, Gracie Vargas, Alexander N. Freiberg

Summary: Researchers have developed a human fetal brain neural stem cell system that can replicate POWV and WNV infections in vitro. They found that both viruses can infect human neurons and astrocytes, but WNV infection triggers a stronger inflammatory response and apoptosis pathways activation compared to POWV. The researchers also observed structural abnormalities in the neurons infected with POWV, similar to previous findings with TBEV-infected neurons. This study provides important insights into the mechanisms of infection and disease development caused by these viruses.

PATHOGENS (2022)

Article Virology

Differences in Genetic Diversity of Mammalian Tick-Borne Flaviviruses

Kassandra L. Carpio, Jill K. Thompson, Steven G. Widen, Jennifer K. Smith, Terry L. Juelich, David E. Clements, Alexander N. Freiberg, Alan D. T. Barrett

Summary: The genetic diversities of mammalian tick-borne flaviviruses were examined using next-generation sequencing. Among the viruses studied, Deer Tick virus, Alkhurma hemorrhagic fever virus, and Kyasanur Forest Disease virus showed low genetic diversity, while Powassan virus exhibited high genetic diversity. The level of genetic diversity could be attributed to the number of tick vector species and amplification hosts each virus can occupy.

VIRUSES-BASEL (2023)

Article Biology

Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkey

Gabriella Worwa, Timothy K. Cooper, Steven Yeh, Jessica G. Shantha, Amanda M. W. Hischak, Sarah E. Klim, Russell Byrum, Jonathan R. Kurtz, Scott M. Anthony, Nina M. Aiosa, Danny Ragland, Ji Hyun Lee, Marisa St Claire, Carl Davis, Rafi Ahmed, Michael R. Holbrook, Jens H. Kuhn, Erica Ollmann Saphire, Ian Crozier

Summary: Deep characterization of uveitis in a rhesus monkey confirms the association between persistence of Ebola virus RNA and severe immunopathology in the eye, which has broader implications for the prevention and treatment of sight-threatening uveitis in human Ebola virus survivors.

COMMUNICATIONS BIOLOGY (2022)

Article Cell Biology

Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines

Thayne H. Dickey, Rui Ma, Sachy Orr-Gonzalez, Tarik Ouahes, Palak Patel, Holly McAleese, Brandi Butler, Elizabeth Eudy, Brett Eaton, Michael Murphy, Jennifer L. Kwan, Nichole D. Salinas, Michael R. Holbrook, Lynn E. Lambert, Niraj H. Tolia

Summary: Continued vaccination against SARS-CoV-2 is necessary due to waning immunity and emerging variants. A nanoparticle vaccine displaying the spike receptor-binding domain (RBD) has been developed, with improvements in stability, immune response, and manufacturing ease. The engineered RBD nanoparticles elicit potent neutralizing antibodies that surpass monomeric RBDs, providing protection against emerging variants.

CELL REPORTS (2023)

Article Virology

Pteropus vampyrus TRIM40 Is an Interferon-Stimulated Gene That Antagonizes RIG-I-like Receptors

Sarah van Tol, Adam Hage, Ricardo Rajsbaum, Alexander N. Freiberg

Summary: The expression of TRIM40 in bat cells during Nipah virus infection helps control the infection by reducing viral titers, while its expression is suppressed in human cells. These findings suggest that bats may achieve tolerance to viral infections by regulating the expression of TRIM40.

VIRUSES-BASEL (2023)

Article Virology

Hemagglutinin affects replication, stability and airborne transmission of the H9N2 subtype avian influenza virus

Naiqing Xu, Xinen Tang, Xin Wang, Miao Cai, Xiaowen Liu, Xiaolong Lu, Shunlin Hu, Min Gu, Jiao Hu, Ruyi Gao, Kaituo Liu, Yu Chen, Xiufan Liu, Xiaoquan Wang

Summary: This study found that the H9N2 subtype avian influenza virus has a high airborne transmissibility, while the H7N9 virus does not. The Hemagglutinin protein of the H9N2 virus was found to play a key role in replication, stability, and airborne transmission.

VIROLOGY (2024)

Article Virology

Contagious ecthyma in Egypt: Clinical, virological and molecular explorations

Samar S. Ewies, Sabry M. Tamam, Ahmed S. Abdel-Moneim, Sherin R. Rouby

Summary: Contagious ecthyma (CE) is a highly contagious viral disease of sheep and goats worldwide. The study provided a clinical description of CE and screened for genetic variation in the B2L gene. Infected sheep exhibited anorexia and oral lesions, while inoculated chicken embryos showed pock lesions. The B2L gene was successfully amplified and found to be highly conserved.

VIROLOGY (2024)

Article Virology

Genetic characterization of newly emerging avian reovirus variants in chickens with viral arthritis/tenosynovitis in Israel

Yigal Farnoushi, Dan Heller, Avishai Lublin

Summary: In recent years, new variants of avian reovirus (ARV) have caused a variety of symptoms in chickens worldwide, including viral arthritis/tenosynovitis. This study analyzed emerging ARV variants in Israel and found significant genetic diversity. Most ARV isolates in Israel belonged to genotypic cluster 5 (GC5). The study suggests that Israel has not experienced the emergence of new ARV variants since the introduction of the live vaccine (ISR-7585), but ongoing monitoring is needed due to the continuous emergence of ARV variants.

VIROLOGY (2024)

Article Virology

Mutations in the 3′ non-coding region of a no-known vector flavivirus Yokose virus increased its replication ability in mosquito C6/36 cells

Shigeru Tajima, Michiyo Kataoka, Yuki Takamatsu, Hideki Ebihara, Chang-Kweng Lim

Summary: Yokose virus (YOKV), a bat-associated flavivirus, was found to replicate at a slower rate in mosquito cells compared to other mosquito-borne flaviviruses. Specific nucleotide mutations in the virus were identified to enhance its proliferation ability in mosquito cells.

VIROLOGY (2024)

Article Virology

Innate immune responses reverse HIV cognitive disease in mice: Profile by RNAseq in the brain

Alejandra Borjabad, Baojun Dong, Wei Chao, David J. Volsky, Mary Jane Potash

Summary: This study investigated HIV brain disease using a mouse model, and found that poly I:C can reverse associated cognitive impairment and reduce virus burden. The results also revealed transcriptional changes related to neuronal function and innate immune responses.

VIROLOGY (2024)

Article Virology

Identification of subgenomic mRNAs derived from the coronavirus 1a/1b protein gene: Implications for coronavirus transcription

Ching-Hung Lin, Feng-Cheng Hsieh, Meilin Wang, Chieh Hsu, Hsuan-Wei Hsu, Chun-Chun Yang, Cheng-Yao Yang, Hung-Yi Wu

Summary: This study demonstrates that the synthesis of coronavirus subgenomic mRNA is not solely determined by the sequence homology between the leader TRS and TRS-B, but also by the disassociation of the coronavirus polymerase from the viral genome. This finding provides a new insight into the transcription mechanism of coronaviruses.

VIROLOGY (2024)

Article Virology

Expression dynamics of the aplysia abyssovirus

Nicholas S. Kron, Benjamin W. Neuman, Sathish Kumar, Patricia L. Blackwelder, Dayana Vidal, Delphina Z. Walker-Phelan, Patrick D. I. Gibbs, Lynne A. Fieber, Michael C. Schmale

Summary: Two recent studies documented the genome of a novel virus in marine animals, finding that the virus is widespread in apparently healthy animals but not highly expressed in neurons. The studies also identified viral replication factories and high levels of defective genomes in chronically infected animals.

VIROLOGY (2024)

Article Virology

Molecular detection and characterization of highly pathogenic H5N1 clade 2.3.4.4b avian influenza viruses among hunter-harvested wild birds provides evidence for three independent introductions into Alaska

Andrew M. Ramey, Laura C. Scott, Christina A. Ahlstrom, Evan J. Buck, Alison R. Williams, Mia Kim Torchetti, David E. Stallknecht, Rebecca L. Poulson

Summary: We successfully detected and characterized highly pathogenic avian influenza viruses in hunter-harvested wild waterfowl samples from western Alaska. Genomic analysis revealed three independent viral introductions into Alaska. Our findings demonstrate the utility and potential limitations of using molecular processing approaches directly on original swab samples for viral research and monitoring.

VIROLOGY (2024)

Article Virology

Inhibitory effects of quercetin on porcine epidemic diarrhea virus in vitro and in vivo

Ting Gong, Dongdong Wu, Yongzhi Feng, Xing Liu, Qi Gao, Xiaoyu Zheng, Zebu Song, Heng Wang, Guihong Zhang, Lang Gong

Summary: This study discovered that quercetin can inhibit PEDV replication both in vivo and in vitro, and alleviate the clinical symptoms and intestinal injury caused by the virus. This provides a new direction for the development of PED antiviral drugs.

VIROLOGY (2024)

Article Virology

Reassortant H9N2 canine influenza viruses containing the pandemic H1N1/ 2009 ribonucleoprotein complex circulating in pigs acquired enhanced virulence in mice

Min Zhu, Hao Zeng, Jianqiao He, Yaohui Zhu, Pingping Wang, Jianing Guo, Jinfan Guo, Huabo Zhou, Yifeng Qin, Kang Ouyang, Zuzhang Wei, Weijian Huang, Ying Chen

Summary: The reassortment between avian H9N2 and Eurasian avian-like (EA) H1N1 viruses may have potentially changed from avian-to-mammals adaptation. This study found that the introduction of EA H1N1 internal genes into H9N2 virus restored the replication capability and resulted in extreme virulence in some cases. This raises new concerns for public health due to the possible coexistence of H9N2 and EA H1N1 viruses in dogs.

VIROLOGY (2024)